Ledger.Open graph →
SEC Form D · filed April 15, 2024

Alphyn Biologics, Inc

Offering
$5.2M
Sold
$5.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANNAPOLIS, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Roger Griggs · Annapolis, MDDirectorNeal Koller · Annapolis, MDExec · DirectorGary Pekoe · Annapolis, MDExec · DirectorAdel Mikhail · Annapolis, MDDirectorSteven Pentelnik · Annapolis, MDDirectorJeffrey Kossak · Annapolis, MDDirectorGary Pekoe · Annapolis, MDExec · DirectorSteven Pentelnik · Annapolis, MDDirectorNeal Koller · Annapolis, MDExec · DirectorAdel Mikhail · Annapolis, MDDirectorRoger Griggs · Annapolis, MDDirectorJeffrey Kossak · Annapolis, MDDirectorTony Shipley · Cincinnati, OHDirectorShannon Kaustinen · Vancouver, British Columbia, CanadaDirectorAngela Doll · Vancouver, British Columbia, CanadaDirectorDavid Van Seters · Vancouver, British Columbia, CanadaExec · DirectorDalco GP I, LLC · Irvine, CADirectorScott Dragoo · NEW YORK, NYDirectorDavid Lin · NEW YORK, NYExec · DirectorTony Shipley · Cincinnati, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗